LENZ vs LKQ · rev $7.4M vs P/E 14, rev $6.88B
LENZ Therapeutics Inc (LENZ) versus LKQ Corporation (LKQ) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
LKQ Corporation (LKQ) is a auto parts company listed on US.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
LENZ currently screens at market cap $223.6M. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
Not investment advice. Open the LENZ and LKQ stock pages for the full models.
Not investment advice.